FIELD: medicine, pharmaceutics.
SUBSTANCE: claimed invention relates to pharmaceutical solutions, suitable for per oral introduction, which have pH in range from approximately 4 to approximately 5, which include 20-50 mg/ml of β-L-thymidine/2'-deoxy-L-thymidine (telbivudin) or its pharmaceutically acceptable salt, sodium saccharin, at least one agent, which improves taste/masks unpleasant taste, system of preservatives and system of buffer substances, suitable for ensuring both stability and preservation of medicine.
EFFECT: obtaining novel pharmaceutical solutions.
13 cl, 3 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| AQUEOUS RISPERIDONE COMPOSITIONS | 1995 |
|
RU2161965C2 |
| PREGABALIN COMPOSITION | 2004 |
|
RU2352333C2 |
| PHARMACEUTICAL COMPOSITION OF VALSARTAN | 2008 |
|
RU2487710C2 |
| HARD DRUG FORM CONTAINING ACTIVE AGENT WITH DISGUISED TASTE | 2007 |
|
RU2437657C2 |
| LIQUID COMPOSITIONS CONTAINING VALSARTAN | 2008 |
|
RU2488393C2 |
| PHARMACEUTICAL COMPOSITION CONTAINING 5-METHYL-2-(2′-CHLORO-6′- FLUOROANILINE)PHENYLACETIC ACID | 2004 |
|
RU2363462C2 |
| LIQUID PHARMACEUTICAL COMPOSITION (VERSIONS) AND METHOD FOR PHOSPHOR BINDING IN GASTROINTESTINAL TRACT | 2007 |
|
RU2463060C2 |
| PHYSICALLY AND CHEMICALLY STABLE ORAL SUSPENSION OF GIVINOSTAT | 2016 |
|
RU2721396C2 |
| THE COMPOSITION OF FENFLURAMINE, COMPATIBLE WITH A KETOGENIC DIET | 2018 |
|
RU2778848C2 |
| LIQUID DOSAGE FORM OF FENSPIRIDE AND PRODUCTION METHOD THEREOF | 2015 |
|
RU2607965C1 |
